Abstract | BACKGROUND AND AIM: We have focused on sodium alginate (SA) solution as a potential submucosal injection material for endoscopic submucosal dissection (ESD). A previous SA solution had high viscosity and problems such as difficult handling. After its properties were adjusted, SA solution was examined in vitro and its clinical safety was evaluated. METHODS: RESULTS: Compared with 0.4% SH solution, 0.6% SA solution exhibited no significant difference in catheter injectability but significant superiority in mucosa-elevating capacity. In the clinical study, no adverse events were observed in any patient. CONCLUSION: The safety of 0.6% SA solution as a submucosal injection material was confirmed and it is suggested that its efficacy should be investigated in a larger number of cases.
|
Authors | Toru Kusano, Tsuyoshi Etoh, Tomonori Akagi, Yoshitake Ueda, Hidefumi Shiroshita, Kazuhiro Yasuda, Masahiro Satoh, Masafumi Inomata, Norio Shiraishi, Seigo Kitano |
Journal | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
(Dig Endosc)
Vol. 26
Issue 5
Pg. 638-45
(Sep 2014)
ISSN: 1443-1661 [Electronic] Australia |
PMID | 24655031
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | © 2014 The Authors. Digestive Endoscopy © 2014 Japan Gastroenterological Endoscopy Society. |
Chemical References |
- Alginates
- Biocompatible Materials
- Drug Carriers
- Hexuronic Acids
- Glucuronic Acid
|
Topics |
- Aged
- Alginates
(administration & dosage)
- Animals
- Biocompatible Materials
(administration & dosage)
- Dissection
(methods)
- Drug Carriers
- Early Detection of Cancer
- Female
- Gastric Mucosa
(pathology, surgery)
- Gastroscopy
(methods)
- Glucuronic Acid
(administration & dosage)
- Hexuronic Acids
(administration & dosage)
- Humans
- Injections
- Male
- Middle Aged
- Neoplasms, Experimental
- Prospective Studies
- Stomach Neoplasms
(diagnosis, surgery)
- Swine
- Treatment Outcome
|